Portal de Periódicos da CAPES

Final Results on Efficacy and Safety of Biosimilar Infliximab after One-Year: Results from a Prospective Nationwide Cohort

2017; Elsevier BV; Volume: 152; Issue: 5 Linguagem: Inglês

10.1016/s0016-5085(17)31554-8

1528-0012

K Gecse, Zsuzsanna Végh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, Petra A. Golovics, Barbara D. Lovász, Lóránt Gönczi, J Banai, László Bene, Beáta Gasztonyi, Tünde Kristóf, L. Lakatos, Pál Miheller, Ferenc Nagy, Károly Palatka, Mária Papp, Árpád V. Patai, Á Salamon, T Szamosi, Zoltán Szepes, Gábor Tamás Tóth, Áron Vincze, Tamás Molnár, Péter L. Lakatos,

Health Systems, Economic Evaluations, Quality of Life

Table 1.Course of the IFX